Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)Business Wire • 27 days agoKezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation...